Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Enphase Energy Prices IPO At $6/share, At Low End Of Revised Range

Enphase Energy, a provider of microinverter solutions for the solar industry, announced the pricing of its initial public offering of 8.97 million shares of common stock at $6.00 per share, at the low end of the revised range of $6 to $7.

In an amended regulatory filing with the U.S. Securities and Exchange Commission on March 28, the company brought down its price range to $6 and $7 per share from its earlier range of $10 to $12 per share. The company had originally filed to offer 7.3 million shares.

The Petaluma, California-based company plans to list on the NASDAQ under the symbol ENPH.

Morgan Stanley, BofA Merrill Lynch and Deutsche Bank Securities acted as lead managers on the deal.

Click here to receive FREE breaking news email alerts for Enphase Energy, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.